Message #10 From:
NewsBot Date: November 21, 2006 09:25:00 AM
CMED News China Medical Technologies, Inc. Closes Offering of US$150 Million Convertible Senior Subordinated Notes
BEIJING--(BUSINESS WIRE)--China Medical Technologies, Inc. (Nasdaq: CMED) today announced the
closing of the offering of US$150 million principal amount of 3.5%
Convertible Senior Subordinated Notes due 2011 to qualified
institutional buyers pursuant to Rule 144A under the Securities Act of
1933, as amended (the “Securities Act”).
The aggregate principal amount of notes sold reflects the exercise in
full by the initial purchaser of its option to purchase up to an
additional US$25 million aggregate principal amount of the notes to
cover over-allotments.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy securities. Any offers of the securities
will be made only by means of a private offering memorandum. The
securities offered have not been registered under the Securities Act or
the securities laws of any other jurisdiction and may not be offered or
sold in the United States absent registration or an applicable exemption
from registration requirements.
About China Medical
China Medical Technologies is a leading China-based medical device
company that develops, manufactures and markets products using high
intensity focused ultrasound for the treatment of solid cancers and
benign tumors and advanced in-vitro diagnostics products using enhanced
chemiluminescence technology, to detect and monitor various diseases and
disorders. For more information, please visit our website at www.chinameditech.com.
